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and the earliest DN1 precursors in the fetal thymusDivision of Biology 156-29
(Akashi et al., 2000; Hattori et al., 1996) to mature SPCalifornia Institute of Technology
thymocytes (Nawijn et al., 2001). In the periphery CD4Pasadena, California 91125
T cells express GATA-3 more strongly than do CD8
T cells (George et al., 1994).
Although disruption of GATA-3 in the mouse germlineSummary
caused embryonic death between E11 to E12, preclud-
ing the analysis of its role in T cell development (PandolfiGATA-3 is expressed at higher levels in CD4 than in
et al., 1995), subsequent analysis of RAG-2/ comple-CD8 SP thymocytes. Here we show that upregulation
mentation and wild-type chimeras has shown that thy-of GATA-3 expression in DP thymocytes is triggered
mocytes derived from GATA-3/ ES cells are arrestedby TCR stimulation, and the extent of upregulation
at or before the CD4 CD8 double-negative (DN) stagecorrelates with the strength of the TCR signal. Overex-
(Hendriks et al., 1999; Ting et al., 1996). Blocking GATA-3pression of GATA-3 or a partial GATA-3 agonist during
expression with antisense oligonucleotides inhibitedpositive selection inhibits CD8 SP cell development
further development from fetal liver precursors (Hattoribut is not sufficient to divert class I-restricted T cell
et al., 1996). However, overexpression of GATA-3 inprecursors to the CD4 lineage. Conversely, expression
E14.5 fetal liver or thymocytes also blocks, rather thanof the GATA-3 antagonist ROG or of a GATA-3 siRNA
increases, entry into the T cell lineage (Anderson et al.,hairpin markedly enhances development of CD8 SP
2002a; Taghon et al., 2001). These and other data indi-cells and reduces CD4 SP development. We propose
cate that, although GATA-3 is essential at the earliestthat GATA-3 contributes to linking the TCR signal
stages of T cell development (Kuo and Leiden, 1999),strength to the differentiation program of CD4 and
its expression must be tightly regulated for successfulCD8 thymocytes.
differentiation. In peripheral T cell development, GATA-3
also has a crucial role directing mature CD4 SP T cellsIntroduction
to differentiate as TH2 and not as TH1 effector cells by
regulating the transcription and chromatin configurationMature CD4 and CD8 single-positive (SP) thymocytes
of cytokine genes (reviewed by Ho and Glimcher, 2002;develop from a common precursor pool of CD4/CD8
Murphy et al., 2000).double-positive (DP) thymocytes through a process
Due to the early developmental block imposed bytermed positive selection. Differentiation into either the
disruption of the gene, the role of GATA-3 during laterCD4 or CD8 lineage depends on the specificity of the
stages of thymocyte development has been difficult toT cell receptor (TCR) on the DP cell for peptides pre-
address, and transgenic experiments have been incon-sented on class II or class I major histocompatibility
clusive about a role for GATA-3 in positive selection.complex (MHC) molecules, respectively. Recruitment of
Transgenic mice expressing GATA-3 under the controlthe CD4 or CD8 coreceptors to class II or class I MHC/
of the human CD2 locus control region have an in-TCR complexes induces distinct signals that enable the
creased proportion of CD8 SP cells undergoing celldifferentiating cell to couple its TCR specificity with a
death, reduced CD8 T cell numbers in the periphery, and
program of maturation to an appropriate effector lin-
some thymic lymphomas, but without obvious effects on
eage. The signal delivered by engagement of the CD4
positive selection itself (Nawijn et al., 2001). In an at-
coreceptor and the TCR appears to be stronger (Basson tempt to ablate normal GATA-3 activity, a GATA-3 mu-
et al., 1998; Herna´ndez-Hoyos et al., 2000; Iwata et al., tant reported to antagonize wild-type GATA-3 activity
1996; Legname et al., 2000) and/or longer lasting (Singer, has also been employed. The GATA-3KRRM305-307AAA mutant2002; Yasutomo et al., 2000) than that delivered through (KRRm), which contains a mutation disrupting a con-
engagement of the CD8 coreceptor and the TCR. It re- served KRR motif between the two Zn fingers (Smith et
mains to be determined how this difference in signal al., 1995), binds DNA but is defective in the ability to
strength or duration translates into distinct develop- undergo acetylation and can act as a competitive inhibi-
mental programs. tor in some transactivation contexts (Smith et al., 1995;
One transcription factor differentially expressed be- Yamagata et al., 2000; Zhang et al., 1999). However,
tween CD4 and CD8 SP thymocytes is GATA-3. Origi- this mutant has also been shown to exhibit context-
nally identified as a TCR enhancer binding protein (Ho dependent partial agonist roles instead of antagonism
et al., 1991), GATA-3 has binding sites in a number of (Lee et al., 2000; Ouyang et al., 1998; Takemoto et al.,
T cell-specific genes, including regulatory regions of 2002; Zhang et al., 1999; and this report). Apparently,
Tcr, Tcr, Tcr, Tcr, and Cd8 (reviewed in Kuo and KRRm is capable of carrying out all the repression and
Leiden, 1999). GATA-3, the only member of the GATA chromatin-remodeling functions of wild-type GATA-3,
but not the direct transactivation functions (e.g., on the
IL-5 promoter). Transgenic mice expressing KRRm un-*Correspondence: alberola@caltech.edu (J.A.-I.), evroth@its.caltech.
edu (E.V.R.) der the control of the Lck distal promoter display defec-
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tive homing of peripheral T cells to lymphoid tissues the stage(s) at which the GATA-3 expression levels di-
verge between cells taking the CD4 and CD8 pathways,and prolonged survival after activation, suggesting a
GATA-3 role in peripheral homeostasis (Yamagata et al., quantitative real-time RT-PCR was used to analyze
mRNAs from progressive developmental series of2000). The low levels of transgene expression observed
in the thymus of these mice, together with the alternative sorted thymocyte subpopulations. In agreement with a
previous report (Nawijn et al., 2001), the highest levelsmodes of KRRm action, complicate the interpretation
of the KRRm phenotype, leaving unresolved the ques- of GATA-3 were found in a CD4 CD8lo CD69 TCRhi
population (see Supplemental Figure S1 at http://www.tion of whether GATA-3 has a role in positive selection
and CD4/CD8 lineage choice. immunity.com/cgi /content/full/19/1/83/DC1) that
contains precursors for both the CD4 and CD8 SP sub-We have taken a different approach to studying the
role of GATA-3 during late stages of thymic develop- sets (reviewed in Germain, 2002; Singer, 2002). To com-
pare the CD4 and CD8 developmental series, positivement. Since GATA-3 is upregulated during development
of CD4 but not CD8 SP thymocytes, we have tested selection intermediates were obtained from either MHC
class I- (2-microglobulin/) or MHC class II-deficientwhether GATA-3 levels are regulated by the TCR signal.
We show that GATA-3 protein levels in thymocytes re- (I-A/ I-Eb) mice to guarantee the CD4 or CD8 lineage
of the sorted populations, respectively. These intermedi-spond directly to TCR signals with differential induction
in response to strong versus weak TCR/Lck signals. We ates were fractionated by their levels of TCR and CD69
expression and subsequently analyzed for CD4 and CD8then used retroviral infection of T cell precursors and
fetal thymic organ culture (FTOC) to analyze the role of expression as shown in Figure 1B. GATA-3 mRNA levels
increase to a maximum in CD69 CD4 lineage intermedi-GATA-3 during positive selection and CD4/CD8 differen-
tiation. Our results indicate that overexpression of ates and then gradually decrease as the cells develop
into CD4 SP mature cells (Figure 1C). This expressionGATA-3 or GATA-3 KRRm specifically inhibits the devel-
opment of CD8 SP thymocytes, while expression of the profile parallels that of the Egr-1 gene in the same cells
(Figure 1C, lower panels), which is induced by TCR sig-GATA-3 antagonist ROG (Miaw et al., 2000) or reduction
of endogenous GATA-3 levels by expression of small naling (Shao et al., 1997). No GATA-3 upregulation was
seen in any CD8 SP development intermediate, and ac-interfering RNAs (siRNA) potentiates CD8 SP generation
and inhibits CD4 SP development. We thus propose a tually the levels decline as the cells differentiate (Fig-
ure 1C, right). The lack of GATA-3 mRNA upregulationmodel whereby GATA-3 levels act as one of the media-
tors of the effect of TCR signal strength on the CD4/ was also observed in thymocyte series sorted from class
I-restricted RAG-2-deficient mice (Supplemental Fig-CD8 lineage decision of thymocytes.
ure S1).
Results
GATA-3 Is Upregulated by DP Thymocytes
in Response to TCR Stimulation, and Its LevelsGATA-3 Is Upregulated Early during Positive Selection
of CD4 but Not CD8 SP Cells of Expression Correlate with the Strength
of the TCR SignalThe expression of GATA-3 during thymocyte develop-
ment was previously monitored in mice through the use The time course of GATA-3 expression resembles that
of Egr-1 sufficiently to suggest that it could be stimu-of a Gata3 knockin lacZ reporter gene (Hendriks et al.,
1999; Nawijn et al., 2001). To verify that the lacZ activity lated by TCR signaling. To test this directly, naive thy-
mocytes from MHC null mice (2-microglobulin/ I-A/pattern described reflects the levels of GATA-3 protein
present in the cells at each stage, we extended this I-Eb; MHC/), consisting of 92% DP thymocytes, were
stimulated in vitro with plate-bound anti-CD3 mAbs, andanalysis by Western blotting and quantitative real-time
RT-PCR analysis of GATA-3 RNA expression, as shown induction of GATA-3, Egr-1, and surface CD69 was mon-
itored at various time points. Stimulation with plate-in Figure 1. Analysis of whole-cell extracts showed that
GATA-3 protein expression decreases sharply as cells bound anti-CD3 led to upregulation of Egr-1 within 1 hr
with upregulation of GATA-3 and surface CD69 followingdifferentiate from the CD4 CD8 DN to the DP stage
and then increases 5-fold in the CD4 SP but not the at 3 hr (Figure 2A). In wild-type total thymocytes, many
of which have undergone TCR-MHC interactions in vivo,CD8 SP thymocytes after positive selection (Figure 1A).
In the most immature cells, GATA-3 levels may also be the initial level of GATA-3 was higher, but the level of
GATA-3 after culture was also increased by anti-CD3lower, spiking transiently after  selection, since RAG-
2/ DN thymocytes, which cannot undergo  selection, treatment (data not shown).
As an alternative in vitro model for TCR stimulationalso contain a low level of GATA-3 protein comparable
to that in DP cells (Figure 1A, right). Thus, elevation of we used CD3/CD4 and CD3/CD3 bispecific F(ab)2 anti-
bodies (Basson et al., 1998). Unlike plate-bound anti-GATA-3 protein is associated with  selection and with
the positive selection of CD4 SP thymocytes specifically. CD3, the bispecific antibodies lack Fc and engage
surface molecules without extensive crosslinking or tar-Quantitative analysis of RNA expression in DN, DP, and
CD4 and CD8 SP populations showed the same pattern, geting to antigen-presenting cells, thus leading to
weaker but sustained TCR stimulation. The CD3/CD4indicating that these changes in GATA-3 expression in
thymocytes are largely controlled at the RNA level, in antibodies bring more Lck to the complex, therefore
inducing a signal stronger than that induced by the CD3/agreement with previous reports (Nawijn et al., 2001)
(see legend to Figure 1A). CD3 antibodies. Stimulation of DP thymocytes with solu-
ble anti-CD3/CD4 upregulated Egr-1, GATA-3, and sur-Positive selection initiates developmental programs
that extend over a period of a week or more. To assess face CD69 with slower kinetics than plate-bound anti-
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Figure 1. Expression of GATA-3 Is Upregulated during Development of Mature CD4 but Not CD8 Thymocytes
(A) Western blot analysis of GATA-3 protein in whole-cell extracts obtained from the indicated purified adult thymocyte populations. Left:
CD4 CD8 TCR DN (DN), CD4 CD8 TCR from MHC/ mice (DP), TCRhi CD4 CD8 SP (CD4 SP), and TCRhi CD4 CD8 SP (CD8 SP).
Right: Immature TCRlo CD4 CD8 SP (CD8 ISP), DN as in (A), thymocytes from RAG-2/ mice (RAG-2/). The numbers of cells loaded per
lane are indicated. The ratio of GATA-3 to Sp1 expression, a control for protein loading, is shown in arbitrary units. *, detection is too low to
be significant. Two separate sets of populations were sorted and analyzed to confirm these results. The corresponding values of GATA-3/
GAPDH ratios as determined by real-time quantitative RT-PCR analysis of the same cell preparations at left are DP, 1; CD4 SP, 2.58; and
CD8 SP, 0.72.
(B) CD4 and CD8 series of thymocytes in developmental progression from DP to SP were sorted from MHC class I- or class II-deficient mice,
respectively. Two independent CD4 series and CD8 series were sorted based on the expression of TCR and CD69 as shown: A to D gates.
Each series was derived from the pooled thymocytes of two mice. The ungated postsort CD4 and CD8 analysis of the subpopulations is
shown.
(C) Quantitative real-time RT-PCR analysis of GATA-3 and Egr-1 expression in the CD4 and CD8 intermediate thymocyte populations shown
in (B). The values graphed show a relative comparison between GATA-3 and Egr-1 expression.
CD3 (Figure 2B). Expression of Egr-1 was first detectable in CD4 and CD8 lineage differentiation. This was tested
by overexpressing GATA-3 in fetal thymocyte precur-at 3 hr (Supplemental Figure S2), peaked at 6 hr, and
sors, using bicistronic retroviral constructs encodingwas maintained through 12 and 24 hr, while upregulation
GFP (Heemskerk et al., 1997). In addition to wild-typeof GATA-3 was first detected at 6 and increased by 12
GATA-3, we examined the previously mentioned mutantand 24 hr (Figure 2B). Treatment of cells with anti-CD3/
form of GATA-3, KRRm. To evaluate whether the mutantCD3 induced a transient expression of Egr-1 that was
acts as a competitive inhibitor or as a partial agonist instill detectable at 6 hr (Figure 2B and Supplemental
this context (see Introduction), we compared the imme-Figure S2 at http://www.immunity.com/cgi/content/full/
diate gene expression effects of GATA-3 and KRRm19/1/83/DC1). However, it did not significantly increase
constructs in immature lymphoid cells. E14.5 fetal thymo-CD69 expression, and upregulation of GATA-3 was only
cytes were transduced with the expression constructsdetected at a modest level within 6 to 24 hr (Figure 2B).
or empty-vector, then sorted to isolate GFP-expressingThus, TCR signaling in vitro induces GATA-3 protein
cells 20 hr later, and processed immediately for RNAaccumulation, with the intensity and kinetics of the in-
preparation. Both GATA-3 and KRRm were expressedduction reflecting the signal strength.
at similar levels in this system: Figures 3A and 3B show
in each case an20-fold increase in protein and an40-
Effects of GATA-3 and GATA-3 KRRm fold increase in RNA over endogenous levels. Moreover,
on Gene Expression neither GATA-3 nor KRRm transgenes induce significant
The characteristics of GATA-3 expression in the CD4 change in the expression of endogenous GATA-3 mRNA
and CD8 lineages and its regulation in response to TCR in the same cells (Figure 3B, GATA-3 3utr).
We analyzed the effect of GATA-3 and KRRm on asignal strength suggested that GATA-3 could play a role
Immunity
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Figure 2. GATA-3 Expression Is Quantitatively Regulated by TCR Signals
Analysis of GATA-3 and Egr-1 protein expression (top), and surface CD69 expression (bottom) on MHC/ thymocytes stimulated in vitro for
the indicated times with (A) plate-bound anti-CD3 mAb, or (B) soluble anti-CD3/CD3 (3/3) or anti-CD3/CD4 (3/4) bispecific antibodies. Viabilities
at 12 and 26 hr were 70% and 50%, respectively; in (B) cells were ficolled to remove dead cells. In (A) Sp1 is used as a protein loading control.
Cells were adjusted to 0.5  106 cell to equivalents/lane.
set of previously defined GATA-3 response genes in overexpression, we used magnetic depletion of CD25
and CD44 cells to purify DP and post- selection DNearly lymphocytes (Anderson et al., 2002a). Figure 3C
E16.5 thymocytes from MHC/mice before transducingshows that for both activating (Hes-1, SCL) and repres-
them with empty retrovirus or retrovirus encoding wild-sive (pre-T, PU.1) effects, KRRm overexpression had
type GATA-3 or KRRm. The infected thymocytes werean effect similar to overexpression of GATA-3. These
immediately reaggregated with stromal cells derivedresults were seen with two independent sets of retroviral
from deoxyguanosine-treated E15.5 fetal thymic lobesconstructs, one cloned into the MIG vector (Exp 1) and
and cultured in reaggregate FTOC (RgFTOC) for up to 2another cloned into the LZRS vector (Exp 2; see Experi-
weeks to follow the kinetics of thymocyte differentiationmental Procedures). Of numerous other genes tested,
from the DP to the CD4 and CD8 SP stages (Figureslisted in Figure 3D, there were no cases in which KRRm
4B–4E). This approach allowed significant numbers ofshowed effects opposite to those of GATA-3. Either both
GATA-3-transduced cells to develop into the TCRhiaffected expression similarly or neither form of GATA-3
stages (Figure 4B). The viability and development ofhad an effect. Thus, KRRm acts as an agonist for GATA-3
the cells transduced with empty vector was similar toeffects in these cells.
uninfected cells, as shown by the constant ratio of GFP
TCRhi:GFP TCRhi cells in these cultures (Figure 4B).
Sustained Overexpression of GATA-3 Favors Cells gated on TCR versus GFP as shown in Figure 4C
Selection of CD4 over CD8 SP Cells were subsequently analyzed for CD4 and CD8 expres-
in Thymic Organ Culture sion (Figure 4D). Two to three individual test lobes were
Since GATA-3 expression is increased during CD4 de- analyzed per time point, and the results of each are
velopment, but not during CD8 development, sustained shown (Figure 4E). In each experiment in this system,
high levels of GATA-3 expression could differentially the GFP cells serve as an additional internal control
affect CD4 and CD8 lineage differentiation. Fetal thymic for the GFP-transduced cells in the same lobe.
organ culture (FTOC) of retrovirally transduced precur- During the first 5 days of culture in this system, a wave
sors provides a kinetically sensitive way to test this of cells progresses from the DP (TCRlo/) to the CD4
prediction. The use of fetal thymocytes from embryonic and CD8 SP (TCRhi) stages. In control GFP cells in all
stages E14.5 to E16.5 allows transduction of precursors samples and in populations infected with empty vector,
at different developmental stages (DN to DP). Overex- there is a surge in the production of TCRhi cells at day
pression of GATA-3 in early thymocyte precursors from 5, followed by maintenance of both TCRhi and TCRlo
E14.5 or E15.5 embryos induces a rapid loss of cellularity populations for at least 4 more days (data not shown).
(Anderson et al., 2002a; Taghon et al., 2001; and data In this culture system CD4 SP cells appear in the TCRhi
not shown). This rapid loss in cellularity consistently population first, followed by a later rise in the numbers
precluded development of a significant number of TCRhi of mature CD8 SP cells (see Figure 4D, TCRhi GFP and
cells (Figure 4A, left panel, gated as shown in Figure TCRhi GFP vector). Along with the effect on viability in
4C) but suggested increased CD4 to CD8 ratios in the the TCRhi population, overexpression of GATA-3 consis-
surviving cells (data not shown). tently resulted in a decrease of the percentage of CD8
SP within this population (Figure 4E, bottom), both atTo try to circumvent these early effects of GATA-3
GATA-3 Role in CD4/CD8 Lineage Development
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Figure 3. Short-Term Effects of GATA-3 and KRRm on Gene Expression in E14.5 Thymocytes
(A) Wild-type and KRRm GATA-3 constructs are similarly overexpressed in E14.5 thymocytes. Western blot analysis of whole-cell extracts
obtained from untransduced () or E14.5 thymocytes transduced with wild-type GATA-3 or KRRm constructs (LZRS vector) and sorted for
GFP expression 20 hr later. Expression of GATA-3 and Sp1 is shown. The numbers of cells loaded per lane are indicated. The geometric
mean of the ratio of GATA-3 to Sp1 expression for each set of three samples is shown in arbitrary units below the corresponding lanes.
Another independent experiment gave comparable results.
(B) Expression of GATA-3 or KRRm does not induce expression of endogenous GATA-3. Samples of thymocytes transduced with empty
vector, GATA-3, or KRRm were prepared as in (A) and analyzed by quantitative real-time RT-PCR. Values for total GATA-3 (using primers for
coding sequence), endogenous GATA-3 (using primers against the 3 untranslated region-3utr), and EGFP (control for transduction) were
normalized to GAPDH values.
(C) E14.5 thymocytes were transduced with wild-type or KRRm GATA-3 cloned in MIG (Exp 1) or LZRS (Exp 2) vector. Twenty hours later,
GFP cells were sorted and subsequently analyzed for RNA expression using real-time RT-PCR. The panels show the values of Hes-1, pre-
T, SCL, and PU.1 normalized to equal inputs by GAPDH values and expressed as a ratio to the empty-vector transduced samples.
(D) Genes unaffected by GATA-3 or KRRm overexpression. Fetal (E14.5 or E16.5) or adult thymocytes from C57BL/6 (B6) or MHC/ mice
were transduced with empty vector, GATA-3, or KRRm in the MIG or LZRS vector, and sorted for GFP expression 20 hr later. Where indicated,
cells were also sorted for CD4 and CD8 expression (DP). One set of E16.5 MHC/ thymocytes was cultured in RgFTOC for 40 hr, then sorted
for GFP, CD4, and CD8 expression (DP/Rg). Expression of the indicated genes was analyzed by quantitative real-time RT-PCR, and values
were normalized to GAPDH or HPRT. All results shown are based on analyses comparing both wild-type and KRRm GATA-3 except as noted.
*, data for wild-type GATA-3 only. X, less than 2-fold change between GATA-3, KRR, and empty vector GFP transductants. ↑, greater than
2-fold increase (see [C]). TCRD1: detection of main germline transcripts. GATA-3 3utr: only detects endogenous GATA-3.
day 7 (one of two lobes) and at day 9 (three of three cases, the GFP cells in the lobe developed normally
showing that CD4:CD8 skewing induced by GATA-3 andlobes). Thus, GATA-3 overexpression appeared to in-
hibit CD8 SP generation more than CD4SP generation KRRm occurs cell autonomously (Figure 4E).
Altogether, these results suggest that overexpression(compare with Figure 4E, top).
Overexpression of GATA-3 KRRm had a less striking of both GATA-3 and KRRm inhibit CD8 development.
This striking effect indicates that the inhibition of CD8 SPeffect on viability (Figure 4B) and led to an even more
substantial increase in the CD4/CD8 ratio (Figure 4D). cell development is not dependent on the mechanisms
through which the wild-type GATA-3 construct causesOverexpression of KRRm resulted in a reduced genera-
tion of CD8SP at days 7 and 9 (all lobes analyzed) and general loss of cellularity and further supports that
KRRm functions as a partial agonist of GATA-3 in thiswas accompanied by a substantial increase in the gener-
ation of CD4 SP cells. Since KRRm affects cellularity to context.
An obvious possible explanation for these resultsa lesser extent, the increase and decrease in CD4 and
CD8 SP cell generation was easily observed in unsepa- would be a direct effect of GATA-3 on the transcription
of CD4 or CD8. However, neither cell surface expressionrated E16.5 thymocytes as well (Figure 4A, right). In all
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Figure 4. Effects of Overexpression of GATA-3 and KRRm on CD4/CD8 Development in RgFTOC
(A) Overexpression of GATA-3 dramatically reduces yield of TCRhi cells whereas KRRm shows a less severe effect. E15.5 thymocytes transduced
with GATA-3, KRRm, or vector control were cultured in RgFTOCs, and one or two lobes of each were analyzed for TCR and GFP expression
(as in [C]) on the days indicated. Left: Ratio of gated TCRhi GFP to TCRhi GFP (uninfected) cells for each individual lobe analyzed, taking
the ratio on day 3 as the unit value. Right: Effect of transduction with KRRm on the generation of CD4 and CD8 SP cells by unfractionated
E16.5 thymocytes. Each column of symbols represents the percentage of CD4 and CD8 subsets within gated TCRhi GFP and TCRhi GFP
populations from individual lobes.
(B–E) Analysis of CD4/CD8 generation in post- selection thymocytes transduced with GATA-3 or KRRm. Thymocytes from E16.5 MHC-
deficient embryos were depleted of CD44 and CD25 cells to generate a population of DN4, CD8ISP, and DP cells. These were subsequently
transduced, cultured in RgFTOC, and analyzed for GFP, TCR, CD4, and CD8 expression on the indicated days.
(B) Ratio of TCRhi GFP to TCRhi GFP populations gated as in (C).
(C) TCR/GFP cytograms showing the percentages of cells within the indicated gates on day 3.
(D) CD4 and CD8 analysis of gated populations from days 3 to 9; the percentages of CD4 and CD8 cells within the TCRhi GFP or GFP
populations are shown. Note that CD4 SP cells are generated before CD8 SP cells.
(E) CD4 and CD8 SP cell analysis of every individual lobe analyzed on days 7 and 9.
analysis (Figure 4D and data not shown) nor RT-PCR eage choice (Figure 3D), raising the possibility that
GATA-3 may act within a previously undescribed devel-analysis (Figure 3D) of GATA-3-transduced adult DP thy-
mocytes or fetal E15.5 (DN1 to DN4) or E16.5 thymocytes opmental gene network.
(DN1 to DP) revealed any change in expression of either
CD4 or CD8, indicating that the inhibition of CD8 SP cell Sustained Expression of GATA-3 Inhibits CD8 SP
Differentiation but Does Not Divert Class I-Restricteddevelopment by GATA-3 is unlikely to result from direct
effects on CD8 or CD4 expression at the DP stage. Precursors into the CD4 Lineage
GATA-3 overexpression could either inhibit develop-Furthermore, RT-PCR analysis did not identify any can-
didates in known pathways related to the CD4/CD8 lin- ment into the CD8 lineage and be tolerated by cells of
GATA-3 Role in CD4/CD8 Lineage Development
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cells developed, all DN. This was consistently observed
on days 5, 6, and 11 after reaggregation in all lobes
analyzed (see figure legend). In another experiment,
overexpression of KRRm was tested with essentially the
same results. In all cases very few, if any, CD4 SP cells
were observed among either GFP or GFP cells in the
cultures with GATA-3- or KRRm-transduced cells. These
results indicate that expression of wild-type and KRRm
GATA-3 can block the development of CD8 SP cells but
may not be sufficient to divert the development of class
I-restricted T cells into the CD4 lineage.
Reduction of GATA-3 Expression or Activity Enhances
CD8 SP Development and Inhibits
CD4 SP Development
The overexpression experiments described above sug-
gest that a high level of GATA-3 inhibits CD8 develop-
ment and either spares or enhances CD4 SP cell devel-
opment. To test whether endogenous GATA-3 might
participate in these roles at normal levels of expression,
we experimentally decreased GATA-3 activity in the
same developmental model in two ways: overexpress-
ing a natural inhibitor of GATA-3, ROG, and decreasing
the levels of GATA-3 using RNA interference (RNAi).
ROG is a BTB/POZ-Zn finger transcription factor
which blocks the ability of GATA-3 to bind to its target
sequences by competitively engaging the GATA-3 Zn
fingers (Miaw et al., 2000). ROG is not expressed nor-
mally in thymocytes or unstimulated peripheral T cells
but is triggered by TCR stimulation in peripheral T cells.Figure 5. Overexpression of GATA-3 Inhibits CD8 Development of
Unlike GATA-3, introduction of ROG into E14.5 or E15.5Class I-Restricted Thymocytes but Does Not Divert Development
fetal thymocytes had little effect on cell recoveries (Fig-into the CD4 Lineage
ures 6A and 6B; GFP versus TCR plot and data notE16.5 LCMV/RAG-2/ thymocytes, which do not express trans-
genic TCR yet, were transduced with empty vector, GATA-3, or shown), enabling unfractionated fetal thymocytes to be
KRRm and cultured in RgFTOC with stromal cells depleted of den- used in these experiments. Notice that, unlike experi-
dritic cells (see Experimental Procedures). A total of vector n 	 8, ments where purified postselection cells were used (Fig-
GATA-3 n 	 5, and KRRm n 	 9 lobes were analyzed on days 5, 6,
ure 4), these conditions allow continuous generation ofand 11, with similar results. The figure shows analysis on day 6.
DP cells from the DN population. Expression of ROGAnalysis on day 11 yielded very few GFP cells. Time points of
resulted in an increase in the generation of TCRhi CD8 SPanalysis were based on pilot analysis of P14 TCR expression in
ontongeny (data not shown). Very few DP cells were ever observed thymocytes in every lobe analyzed in three independent
in RgFTOCs or standard FTOCs using these mice (data not shown). experiments (ROG n	 19; vector n	 18 lobes). A repre-
sentative example is shown in Figures 6A and 6B. En-
hanced CD8 SP development was seen as soon as the
first CD8 SP cells appeared (day 7.5) and was main-the CD4 lineage or it could inhibit CD8 development by
directing development into the CD4 lineage. To distin- tained at later time points (day 12.5). This increase in
CD8 SP generation was accompanied by a reducedguish between these two possibilities, wild-type and
KRRm GATA-3 were transduced into E16.5 recombina- generation of CD4 SP in most cases (16 of 19 lobes)
(Figures 6A and 6B). It is worth mentioning that in thesetion-deficient thymocytes homozygous for the class
I-restricted P14 TCR transgene (LCMV/RAG-2/ thymo- cultures GFP cells normally outnumber GFP cells, mak-
ing the comparison of absolute cell numbers within thesecytes; Pircher et al., 1989) (Figure 5). This TCR is specific
for a lymphocytic choriomeningitis virus (LCMV) peptide populations uninformative, especially in cases where the
viability of the transduced populations is affected (e.g.,presented by H-2Db and induces CD8 development. Im-
portantly for analysis of possible lineage diversion, CD8 GATA-3). However, because ROG-transduced cells sur-
vive at least as well as control cells, the increase in CD8coreceptor expression is not absolutely essential for
development of thymocytes expressing this transgene SP cells reflects an increase in the absolute number of
these cells generated, relative to the equivalent internal(Sebzda et al., 1997). As expected, LCMV/RAG-2/ thy-
mocytes infected with empty vector developed mostly control GFP population (Figure 6A).
To confirm that these effects of ROG were due to itsinto CD8 SP cells expressing high levels of TCRV2
transgenic, although a sizable DN TCRV2hi population ability to inhibit GATA-3, we used RNAi as an indepen-
dent method to decrease GATA-3 expression in DP cells.could also be detected both in the GFP and in GFP
populations (Figure 5). In contrast, overexpression of We used the U6 RNA polymerase III promoter cloned in
the 3 LTR of an M-MLV-based retroviral vector (gener-GATA-3 or KRRm severely blocked the generation of
CD8 SP TCRV2hi cells altogether. Only a few TCRV2hi ously provided by Dr. J. Rossi) to express 21 nt small
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Figure 6. Reduction of GATA-3 Activity or Expression Enhances CD8 SP and Inhibits CD4 SP Thymocyte Development
(A) E14.5 thymocytes were transduced with empty vector or ROG and cultured in RgFTOC. Three lobes of each were analyzed on days 3.5,
7.5, and 12.5. Very few TCRhi cells were detected on day 3.5 (data not shown). CD4 and CD8 analysis of the populations gated on TCR and
GFP are shown for days 7.5 and 12.5.
(B) Left: The percentages of CD4 SP and CD8 SP within the TCRhi GFP and TCRhi GFP populations are plotted for each individual lobe
analyzed. Similar results were obtained in two additional experiments using E15.5 thymocytes.
(C) E16 thymocytes from MHC/ embryos were transduced with retroviral constructs expressing two different siRNA hairpin constructs
bearing the same GATA-3 complementary sequence and either a 4 nt (siRNA-I) or an 8 nt (siRNA-II) loop and analyzed on day 5.5 as in (A).
The effects on generation of CD4 and CD8 SP cells for every lobe analyzed are shown in (B), right panel.
(D) The diagram shows the retroviral siRNA construct with the sense (s) and antisense (as) GATA-3 sequences and the siRNAI/II hairpin
sequence used; loop nucleotides in bold are only present in siRNA-II. Transduction of siRNA-I (s-I) or siRNA-II (s-II), but not empty vector (v),
reduces endogenous GATA-3 protein expression in 16610D9 cells. Expression of GATA-3 in transduced versus untransduced (GFP or GFP)
cells was detected by intracellular staining. Staining with an isotype-matched negative control antibody (dotted gray line) is included. Right:
Specificity of the intracellular staining for GATA-3 is shown in 293 cells, which do not express GATA-3, after transfection with GATA-3 (G3)
or empty vector (v).
interfering RNA hairpins in thymocytes, as described GATA-3 expression were determined by intracellular
staining (Figure 6D). The specificity of the intracellular(Yu et al., 2002) (see diagram in Figure 6D). We selected
different regions in GATA-3 as targets to design candi- staining was verified in transfected 293 fibroblasts after
transfection with control vector or GATA-3 constructsdate siRNAs (Elbashir et al., 2002) and tested their ability
to inhibit GATA-3 expression in a thymoma-derived cell (Figure 6D, right panels). As shown in Figure 6D, GATA-3
expression was significantly reduced in GFP cellsline, 16610D9 (Bain et al., 2001). These cells express
GATA-3 constitutively at very high levels (5-fold above transduced with siRNA-I and -II both directed against
the same GATA-3 sequence but with different lengththe maximum GATA-3 levels inducible in DP thymo-
cytes; data not shown). The cells were infected with hairpin loops; targeting a second GATA-3 sequence had
no effect (data not shown). This change in loop size fromthe different GATA-3 siRNA constructs, and effects on
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4 to 8 nt achieved slightly enhanced inhibition of GATA-3 higher than those induced by the CD2-GATA-3 trans-
gene: 20-fold versus 2-fold overexpression at theat the expense of GFP levels and transduction efficiency
protein level. Different dose-response thresholds could(Figure 6D). We then used these two siRNA constructs
apply for inhibition of different stages of CD8 cell matu-to infect E15.5 wild-type or E16 MHC null thymocytes
ration. A third difference is that the FTOC approach,(Figure 6C). Expression of either GATA-3 RNAi reproduc-
with its limited precursor input and short time course,ibly resulted in a similar increase in the generation of
is less likely to be influenced by selective outgrowthTCRhi CD8 cells and a concomitant decrease in the per-
of a minority population. In the transgenic experimentscentages of TCRhi CD4 cells in all of the RgFTOC lobes
(Nawijn et al., 2001), only CD4 SP cells had increasedanalyzed in four experiments (altogether, n 	 34 for the
GATA-3 levels, suggesting that the only CD8 SP cellstwo siRNAs versus n 	 15 for the vector control). This
generated proceeded from cells that had shut downresult was observed at early and late time points (data
transgene expression. In our retroviral transduction sys-not shown) and phenocopies the effects of ROG. An
tem any cells escaping GATA-3 action by downregulat-siRNA-II construct with two point mutations in the GATA-3
ing vector expression are distinguished a priori by theircomplementary sequence did not affect GATA-3 expres-
reduced levels of GFP.sion or thymocyte development (data not shown).
Both the phenotype of the GATA-3 and KRRm overex-These results confirm that decreasing endogenous
pression and the survey of changes in gene expressionGATA-3 activity promotes CD8 and inhibits CD4 devel-
in response to these two constructs indicate that inopment, while increasing GATA-3 expression inhibits
this context, as in peripheral Th cells (Lee et al., 2000;CD8 development. Therefore, our results suggest that
Ouyang et al., 1998; Takemoto et al., 2002; Zhang etGATA-3 has reciprocal roles in the generation of CD4
al., 1999), KRRm acts primarily as a partial agonist ofand CD8 mature T cells, favoring the former and inhib-
GATA-3, rather than as a dominant-negative form ofiting the latter.
GATA-3, especially in chromatin remodeling or repres-
sion. Strikingly, the ability of KRRm to inhibit CD8 devel-Discussion
opment without profoundly affecting survival or prolifera-
tion shows that these two processes can be decoupled.In this manuscript we present evidence that GATA-3
Thus, the skewing of CD4:CD8 ratios is a discrete, specificexpression can be regulated in vivo and in vitro by the
function of GATA-3 and not merely a side effect of thestrength of TCR signaling in DP thymocytes and that
cell loss seen with the wild-type construct. Furthermore,the level of GATA-3 activity can play an important role
the reciprocal effect on CD4:CD8 ratios caused by re-as a negative regulator of the CD8 differentiation pro-
ducing GATA-3 expression or activity indicates that reg-gram and simultaneously as a positive regulator of CD4
ulation of CD4/CD8 differentiation is likely to be a normaldevelopment. Overexpression of GATA-3 or of a partial
function of GATA-3 in vivo.agonist GATA-3 mutant, KRRm, reduces CD8 cell ap-
TCR-Lck signal strength plays an important role influ-pearance during development of a synchronized cohort
encing whether thymocytes will develop into CD4 cellsof precursors in RgFTOC. Development of CD4 cells is
or into CD8 cells (Herna´ndez-Hoyos et al., 2000; Leg-
relatively spared (GATA-3) or enhanced (KRRm) in this
name et al., 2000; reviewed by Basson et al., 1998). TCR
context. Conversely, the introduction of the GATA-3 an-
signaling has several known effects on gene expression
tagonist ROG or reduction of endogenous GATA-3 levels
in DP thymocytes, but until now it has been difficult to
by specific RNAi accelerates the appearance of CD8 SP link any of these with the subsequent divergence of
cells in RgFTOC and leads to a substantially increased gene expression programs between the CD4 and CD8
yield of CD8 cells and a decrease of CD4 cells. Thus, developmental pathways. The Zn finger transcription
we propose that GATA-3 is one component of the mech- factor Egr-1 and the bHLH antagonist Id3 are induced
anism linking TCR signal strength to the distinct differen- in response to the Ras pathway (Bain et al., 2001; Shao
tiation programs of CD4 and CD8 SP thymocytes. et al., 1997), but changes in Id3 or Egr-1 do not affect
Previous studies using transgenic mice expressing the CD4 and CD8 lineage choice (Bain et al., 1999, 2001;
GATA-3 under the control of T cell-specific promoters Bettini et al., 2002). Recently, two other transcription
have described roles for GATA-3 in mature thymocytes factors have been implicated functionally in CD4 versus
and peripheral T cell development (Nawijn et al., 2001; CD8 cell development, i.e., Runx-family transcription
Yamagata et al., 2000) but have not provided evidence factors and the HMG box factor Tox (Hayashi et al.,
for a role in thymic positive selection itself. In contrast, 2001; Taniuchi et al., 2002; Wilkinson et al., 2002). The
our results show that, under appropriate conditions, ele- Notch pathway has been much discussed as a contribu-
vation of GATA-3 activity can inhibit CD8 cell differentia- tor to CD4/CD8 lineage differentiation, but its mode of
tion, with effects seen as early as the first cohort of CD8 action remains controversial (reviewed in Allman et al.,
SP TCRhi cells arises from DP TCRhi precursors in a 2002; Herna´ndez-Hoyos and Alberola-Ila, 2003). How-
RgFTOC. Several reasons can explain why these effects ever, to date the activities of these differentially acting
are more detectable in our study. First, as opposed to transcription factors have not been shown to be regu-
transgenic systems, where the populations are in steady lated by TCR strength of signal. Additionally, our results
state, we examined the effect of GATA-3 elevation on indicate that GATA-3 overexpression does not affect
a single wave of cells differentiating semisynchronously transcription of any of these potential mediators of CD4/
in organ culture. This approach is more sensitive to CD8 T lineage choice (Figure 4D). It is likely that GATA-3
kinetic alterations. A second difference is that the levels acts on an aspect of CD8/CD4 cell differentiation that
of GATA-3 overexpression achieved in DP cells by ret- has not been analyzed before and may provide access
to a new component of this important process.roviral transduction in our system are substantially
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Figure 7. Models of GATA-3 Effect on CD4/
CD8 Differentiation
(A) Summary of the effect on CD4/CD8 devel-
opment and viability of the four constructs
used.
(B) Positive selection of DP thymocytes into
mature CD4 or CD8 SP cells is a multistep
process that includes lineage commitment,
differentiation, and survival. The tyrosine ki-
nase Lck can translate changes in the inten-
sity of the TCR-CD4/CD8 coreceptor signal
on DP cells into changes in lineage commit-
ment (Herna´ndez-Hoyos et al., 2000; Leg-
name et al., 2000). We propose that the
strength of the TCR-Lck signals determines
the subsequent levels of GATA-3 expression.
Cells receiving strong TCR-Lck signals due
to interaction of TCR and CD4 with MHC class
II molecules induce elevated levels of GATA-3
expression. Cells receiving weak TCR-Lck
signals via interaction of TCR and CD8 with
class I molecules would express little GATA-3.
Two models are shown to indicate how high
or low levels of GATA-3, along with other un-
known factors (??), would promote develop-
ment into the CD4 or CD8 lineages, respec-
tively. GATA-3 could exert its influence on
CD4/CD8 differentiation at (A) the lineage
commitment step, or (B) at the survival and/
or subsequent differentiation steps.
Positive selection of CD4 and CD8 SP cells is a pro- GATA-3 in a uniquely favorable position to link the inten-
sity of the TCR signal to the developmental outcome.cess that includes lineage commitment, differentiation,
and survival. Alterations in Lck signaling levels can divert
Experimental Procedurescells with class I-restricted TCR to a CD4 pathway and
vice versa, demonstrating its effect on lineage commit-
Mice
ment (Herna´ndez-Hoyos et al., 2000). If our results with C57BL/6 (B6), MHC/ (C57BL/6 2-microglobulin/ I-A/ I-E
the class I-restricted TCR system (LCMV/Rag-2/) can null), and C57BL/6-RAG-2/ mice were bred and maintained in the
be generalized, then GATA-3 overexpression is not suffi- mouse facility at Caltech. P14 TCR-transgenic RAG-2/ (RAG-2/
LCMV), C57BL/6 2-microglobulin/ (MHC cl. I/), and I-A/ I-Ecient to redirect the cell lineage of thymocytes express-
null (MHC cl. II/) mice were obtained from Taconic. Adult miceing a class I-restricted TCR. This suggests that TCR-
used were between the ages of 6 and 12 weeks of age. B6D2F1Lck signals require additional effectors besides GATA-3
mice were obtained from Jackson Laboratories. Timed pregnancies
to determine CD4 lineage commitment. Alternatively, were considered day 0.5 on the day of plug.
GATA-3 does not operate at the level of lineage commit-
ment and may reciprocally regulate survival and/or the Retroviral Constructs
subsequent differentiation during CD4 and CD8 devel- The LZRS-IRES-GFP and MIG (MSCV-IRES-GFP) bicistronic retrovi-
ral vectors (Heemskerk et al., 1997; Van Parijs et al., 1999) and theopment (Figure 7).
Banshee retroviral vector (gift from Dr. John Rossi) were used inIn summary, our in vitro stimulation experiments with
the gene transduction experiments. Generation of the GATA-3/LZRSplate-bound anti-CD3 and soluble anti-CD3/CD3 and
retroviral construct was described previously (Anderson et al.,
anti-CD3/CD4 bispecific F(ab)2 antibodies illustrate that 2002a). Generation of the KRRm, ROG, and siRNA/Banshee con-
the GATA-3 induction system is calibrated to respond structs is described in the Supplemental Data at http://www.
to TCR signal strength, even at low magnitudes possibly immunity.com/cgi/content/full/19/1/83/DC1.
relevant for positive selection. The physiological pattern
Purification of Thymocyte Subpopulations by Cell Sortingof expression of GATA-3 in cells developing into the
The cell populations used in Figure 1A were isolated from the indi-CD4 or CD8 lineage further supports the interpretation
cated mice after staining with fluorescently labeled antibodiesthat GATA-3 expression can be regulated quantitatively
against CD4, CD8 ,and TCR (Pharmingen, Becton Dickinson). For
by TCR signaling. Together with the effects on CD4/ Figure 1B, two independent CD4 and CD8 developmental series
CD8 development by increasing or decreasing GATA-3 were sorted from MHC class I- or class II-deficient mice. Each series
was sorted from the pooled thymocytes of two 7-week-old femaleactivity or expression in RgFTOCs, these results place
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mice of each genotype after staining for CD4, CD8, CD69, and TCR J.A.-I is a Cancer Research Institute Investigator. The work was
initiated as a Consortium Project of the Stowers Institute for Medical(Pharmingen, Becton Dickinson). Purity of all sorted populations
was above 95%. Three- and four-color sorts were performed on a Research and then supported by grants to E.V.R. from the NIH
(CA90233) and NSF (MCB-9983129), and to J.A.-I. from the NIHFACS Vantage (Becton Dickinson).
(AI45072) and CRI.
In Vitro Stimulation of Thymocytes
Thymocytes from MHC/ mice were stimulated on anti-CD3 (clone Received: November 5, 2002
2C11; 10 
g/ml) coated plates or with soluble anti-CD4/CD3 or anti- Revised: April 28, 2003
CD4/CD3 F(ab)2 antibodies (10 
g/ml), kindly provided by Dr. Jae Accepted: April 30, 2003
Y. Tso. Cells were harvested at the times indicated and counted. A Published: July 15, 2003
fraction was stained for CD69 expression, and equivalent cell num-
bers were frozen as cell pellets for Western blot analysis. References
Western Blot Analysis Akashi, K., Traver, D., Miyamoto, T., and Weissman, I.L. (2000). A
Whole-cell extracts were prepared from sorted or activated popula- clonogenic common myeloid progenitor that gives rise to all myeloid
tions, electrophoresed in 10% SDS-PAGE gels, and blotted onto lineages. Nature 404, 193–197.
nitrocellulose membranes. Antibodies against GATA-3 (sc-268),
Allman, D., Punt, J.A., Izon, D.J., Aster, J.C., and Pear, W.S. (2002).
Egr-1 (sc-110), or Sp1 (sc-59 or sc-420) (Santa Cruz Biotechnology)
An invitation to T and more: notch signaling in lymphopoiesis. Cell
and horeseradish peroxidase-coupled second stage reagents were
Suppl. 109, S1–S11.
used to develop the blots (ECL PLUS, Amersham Pharmacia). Blots
Anderson, M.K., Herna´ndez-Hoyos, G., Dionne, C.J., Arias, A.M.,were exposed on X-ray film and subsequently scanned by phos-
Chen, D., and Rothenberg, E.V. (2002a). Definition of regulatory net-phorimager using STORM software to determine relative intensity.
work elements for T cell development by perturbation analysis with
PU.1 and GATA-3. Dev. Biol. 246, 103–121.Transduction with Retroviral Constructs
Anderson, M.K., Weiss, A.H., Herna´ndez-Hoyos, G., Dionne, C.J.,Retroviral constructs in the LZRS vector were used to transfect the
and Rothenberg, E.V. (2002b). Constitutive expression of PU.1 inφNX-Eco packaging cell line by calcium phosphate precipitation as
fetal hematopoietic progenitors blocks T cell development at thepreviously described (Anderson et al., 2002b). Retroviral constructs
pro-T cell stage. Immunity 16, 285–296.in the MIG and Banshee-GFP vectors were cotransfected along with
the pCL/Eco plasmid into 293 cells as described (Naviaux et al., Bain, G., Quong, M.W., Soloff, R.S., Hedrick, S.M., and Murre, C.
1996); supernatant was harvested for immediate use 24 to 48 hr (1999). Thymocyte maturation is regulated by the activity of the
after transfection. Purification of post- selection thymocytes and helix-loop-helix protein, E47. J. Exp. Med. 190, 1605–1616.
transduction with retroviral supernatant are described in the Supple-
Bain, G., Cravatt, C.B., Loomans, C., Alberola-Ila, J., Hedrick, S.M.,
mental Data.
and Murre, C. (2001). Regulation of the helix-loop-helix proteins,
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Basson, M.A., Bommhardt, U., Mee, P.J., Tybulewicz, V.L., and Za-females, after 5 to 6 days of culture in DMEM-FTOC (Anderson et
moyska, R. (1998). Molecular requirements for lineage commitmental., 2002b) supplemented with 1.35 mM 2-deoxyguanosine. Trans-
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